Education, Science, Technology, Innovation and Life
Open Access
Sign In

Ethical Problems about Epidemic Prevention and Control for Covid-19 Pandemic Situation

Download as PDF

DOI: 10.23977/jsoce.2021.030421 | Downloads: 2 | Views: 827

Author(s)

Yue Chen 1, Xin PENG 1

Affiliation(s)

1 Guizhou University Humanities and Medical Research Center, Zunyi Medical University, Zunyi 563006, China

Corresponding Author

Yue Chen

ABSTRACT

The COVID-19 outbreak in Wuhan in December 2019 is a public health emergency, which is characterized by unexpected, complex, clustering and staged characteristics. COVID-19 has had a significant impact on China’s economic and social development, caused a huge burden on people’s lives and health, and triggered a series of social and medical ethical problems. The main ethical problems include the restriction of personal freedom, social discrimination, clinical ethics, drug research ethics and so on. The government and society should pay attention to the ethical problems about epidemic prevention and control for COVID-19 pandemic situation. They should understand the causes and processes of these contradictions, and take scientific and effective measures to reduce the overall burden of prevention and control for COVID-19.

KEYWORDS

Covid-19, Public health emergency, Ethical problems

CITE THIS PAPER

Yue Chen, Xin PENG. Ethical Problems about Epidemic Prevention and Control for Covid-19 Pandemic Situation. Journal of Sociology and Ethnology (2021) 3: 117-122. DOI: http://dx.doi.org/10.23977/jsoce.2021.030421.

REFERENCES

[1] Xumao Zhao, Xinhai Li, Changhong Nie.A retrospective study of COVID-19 diffusion trend and epidemic control in China based on big data[J].Proceedings of the Chinese Academy of Sciences, 2020, 35(03):248-255.
[2] National Health Commission. Notification from the Health Commission on the Provisional Naming of COVID-19[ ER/OL ]. http: //www.gov.cn/zhengce/zhengceku/2020-02/08/content_5476248.Htm.
[3] The World Health Organization has named the novel coronavirus-infected pneumonia COVID-19[ER/OL]. http:// www.Xinhuanet.com //world /2020-02/11/c_1125561343.Htm.
[4] The State Council of the People's Republic of China. Regulations on the Management of Public Health Emergencies[EB/OL]. http://www.gov.cn/gongbao/content/2011/content_1860801.htm.
[5] The State Council of the People's Republic of China. Notice on the adjustment of the standards for the division of city size[EB/OL]. http://www.gov.cn/zhengce/content/2014-11/20/content_9225.htm.
[6] Wuhan Prevention and Control Headquarters. Notice of the Municipal Headquarters for the Prevention and Control of Pneumoinflammation Infected by Novel Coronavirus (No. 1)[ER/OL]. https://baijiahao.baidu.com/s?id=1656461350744901349&wfr=spider&for=pc.
[7] People's Publishing House. People's Publishing House of China[M]. People's Publishing House. 2018.
[8] The Standing Committee of the National People's Congress of the People's Republic of China. Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases[ER/OL]. http://www.gov.cn/banshi/2005-08/01/content_19023_2.htm.
[9] Lin Xie, Hualei Yang, Yuanyang Wu. Mortality rate of COVID-19 in healthcare resources and optimal allocation of resources[J]. Economics and management research,2020,41(08):14-28.
[10] Danlong Chen, Fang Yang, Zhiying Luo, Huanzhang Xie, Haiyan Dong, Li Jia. Current status and bottleneck of global anti-novel coronavirus drug development[J]. Chinese Pharmacology Bulletin, 2020, 36(04):459-469.

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.